Associated Papers
Association of Single Nucleotide Polymorphisms in the Cyclooxygenase-2 (COX-2) Gene with Periodontal Disease-A Systematic Review with Meta-Analysis and Implications for Personalized Dentistry.
Savva V et al.
Journal of Personalized Medicine, 2025
Association between two single nucleotide polymorphisms of the Prostaglandin-Endoperoxide Synthase 1 and 2 genes and cell proliferative prostatic diseases in Lebanon.
Sheehan BJ et al.
Oncotarget, 2025
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer.
Drew DA et al.
Science Advances, 2024
Elevated Prostaglandin E2 Synthesis Is Associated with Clinical and Radiological Disease Severity in Cystic Fibrosis.
Gartner S et al.
Journal of Clinical Medicine, 2024
Mutation of the cyclooxygenase 2 gene promoter and anastomotic leakage in colorectal cancer patients: retrospective cohort study.
Grahn O et al.
Bjs Open, 2024
Influence of the Cyclooxygenase-2 Gene -765G/C and -1195G/A Polymorphisms on Development of Ischemic Stroke.
Wu G et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association, 2016
Functional polymorphisms of the cyclooxygenase-2 gene and prognosis of hepatocellular carcinoma - a cohort study in Chinese people.
Liang R et al.
Genetics and Molecular Research : Gmr, 2016
Lack of association between the cyclooxygenase 2 -765G>C polymorphism and prostate cancer risk: a meta-analysis.
Feng YQ et al.
Genetics and Molecular Research : Gmr, 2015
Cyclooxygenase-2 gene polymorphisms and the risk of colorectal cancer: A population-based study.
Li H et al.
Oncology Letters, 2015
Cyclooxygenase-2 polymorphisms and breast cancer associated risk in Pakistani patients.
Moatter T et al.
Pathology Oncology Research : Por, 2015
Cyclooxygenase-2 genetic variants influence intratumoral infiltration of Foxp3-positive regulatory T cells in non-small cell lung cancer.
Yukawa T et al.
Oncology Reports, 2015
COX-2 polymorphisms -765G→C and -1195A→G and hepatocellular carcinoma risk.
Gharib AF et al.
Gene, 2014
PTGS2 gene polymorphism -765G>C is associated with coronary artery disease: a meta-analysis.
Xuan CL et al.
Genetics and Molecular Research : Gmr, 2014
Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.
Peng Q et al.
Plos One, 2014
Functional promoter -765 G > C variant in COX-2 gene is associated with the susceptibility of breast cancer in Chinese Han women.
Gao J et al.
Cancer Cell International, 2014
COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.
Makar KW et al.
Cancer Causes & Control : Ccc, 2013
Influence of Cyclooxygenase-2 (COX-2) gene promoter-1195 and allograft inflammatory factor-1 (AIF-1) polymorphisms on allograft outcome in Hispanic kidney transplant recipients.
Vu D et al.
Human Immunology, 2013
Cyclooxygenase 2 genetic polymorphism may increase the risk of developing leukoaraiosis in Chinese.
Shan XY et al.
Journal of Molecular Neuroscience : Mn, 2013
The association between cyclooxygenase-2 1195 G/A polymorphism and hepatocellular carcinoma: evidence from a meta-analysis.
Bu X et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2013
Association study of polymorphisms in the cyclooxygenase-2 gene and Alzheimer's disease risk in Chinese.
Tang W et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2013
Cyclooxygenase-2 ( COX -2) gene-765G/C polymorphism and advanced-stage endometriosis in Korean women.
Kim HY et al.
American Journal of Reproductive Immunology (new York, N.y. : 1989), 2012
Functional polymorphism of cyclooxygenase-2 gene (G-765C) in chronic obstructive pulmonary disease patients.
Pietras T et al.
Molecular Biology Reports, 2012
Cyclooxygenase-2 polymorphisms and pancreatic cancer susceptibility.
Özhan G et al.
Pancreas, 2011
The cyclooxygenase-2-765C promoter polymorphism protects against the development of chronic obstructive pulmonary disease.
Wu L et al.
Respiratory Medicine, 2011
Cyclooxygenase-2 polymorphisms and susceptibility to esophageal cancer: a meta-analysis.
Liang Y et al.
The Tohoku Journal of Experimental Medicine, 2011
Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma.
Akkız H et al.
Molecular and Cellular Biochemistry, 2011
A polymorphism in the cyclooxygenase 2 gene in type 1 diabetic patients with nephropathy.
Hubáček JA et al.
Physiological Research, 2011
Cyclooxygenase-2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression.
Sakaki M et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology, 2010
Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: a meta-analysis.
Liu JL et al.
World Journal of Gastroenterology, 2010
[Anxiety, depression and polymorphism of the gene encoding superoxide dismutase in patients with chronic obstructive pulmonary disease].
Pietras T et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego, 2010
Functional variants of COX-2 and risk of tobacco-related oral squamous cell carcinoma in high-risk Asian Indians.
Mittal M et al.
Oral Oncology, 2010
Potentially functional COX-2-1195G>A polymorphism increases the risk of digestive system cancers: a meta-analysis.
Dong J et al.
Journal of Gastroenterology and Hepatology, 2010
COX-2 polymorphisms and colorectal cancer risk: a strategy for chemoprevention.
Pereira C et al.
European Journal of Gastroenterology & Hepatology, 2010
The effect of genetic polymorphisms of cyclooxygenase 2 on acute pancreatitis in Turkey.
Ozhan G et al.
Pancreas, 2010
Effect of COX2 -765G>C and c.3618A>G polymorphisms on the risk and survival of sporadic colorectal cancer.
Iglesias D et al.
Cancer Causes & Control : Ccc, 2009
Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma.
Gong Z et al.
International Journal of Colorectal Disease, 2009
Association of polymorphisms in cyclooxygenase (COX)-2 with coronary and carotid calcium in the Diabetes Heart Study.
Rudock ME et al.
Atherosclerosis, 2009
Common single nucleotide polymorphisms in cyclooxygenase-2 and risk of severe chronic periodontitis in a Chinese population.
Xie CJ et al.
Journal of Clinical Periodontology, 2009
Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population.
Srivastava K et al.
Journal of Gastroenterology, 2009
A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.
Cross JT et al.
The Pharmacogenomics Journal, 2008
Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study.
Ueda N et al.
Cancer Science, 2008
Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.
Hubner RA et al.
International Journal of Cancer, 2007
Association of prostaglandin-endoperoxide synthase 2 gene polymorphisms with asthma and atopy in Chinese children.
Chan IH et al.
Allergy, 2007
Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer.
Tan W et al.
Carcinogenesis, 2007
Functional polymorphisms in the cyclooxygenase 2 (COX-2) gene and risk of breast cancer in a Chinese population.
Gao J et al.
Journal of Toxicology and Environmental Health. Part A, 2007
Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis.
Hill MR et al.
American Journal of Respiratory and Critical Care Medicine, 2006
Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors.
Orbe J et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2006
Genetic variants in cyclooxygenase-2: Expression and risk of gastric cancer and its precursors in a Chinese population.
Liu F et al.
Gastroenterology, 2006
Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs.
Lee YS et al.
Clinical Pharmacology and Therapeutics, 2006
Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study.
Park JM et al.
Bmc Cancer, 2006